Natural Killer Cell-triggering Receptors in Patients with Acute Leukaemia

References

• Smyth, M.J., Hayakawa, Y, Takeda, K. and Yagita, H. (2002) "New aspects of natural-killer cell surveillance and therapy of cancer", Nature Reviews Cancer 2, 850–861.
   PubMed Web of Science ®Google Scholar
• Farag, S.S., Fehniger, TA., Ruggeri, L., Velardi, A. and Caligiuri, MA. (2002) "Natural killer receptors: new biology and insights into the graft versus leukemia effect", Blood 100, 1935–1947.
   PubMed Web of Science ®Google Scholar
• Davies, S.M., Ruggieri, L., DeFor, T., Wagner, J.E., Weisdorf, D.J., Miller, J.S., Velardi, A. and Blazar, B.R. (2002) "Evaluation of KW ligand incompatibility in mismatched unrelated donor hematopoie-tic transplants. Killer immunoglobulin-like receptor", Blood 100, 3825–3827.
   PubMed Web of Science ®Google Scholar
• Shilling, HG., McQueen, K.L., Cheng, NW., Shizuru, LA., Negrin, R.S. and Parham, P. (2003) "Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplan-tation", Blood, First Edition Paper, January 2, 2003.
   Google Scholar
• Elkins, W.L., Pickard, A. and Pierson, G.R. (1984) "Deficient expression of class4 HLA in some cases of acute leukemia", Cancer Immunology, Immunotherapy 18, 91–100.
   PubMed Web of Science ®Google Scholar
• Pawelec, G., da Silva, P., Max, H., Kalbacher, H., Schmidt, H., Bruserud, 0., Zugel, U., Baier, W., Rehbein, A. and Pohla, H. (1995) "Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha", Leukemia and Lymphoma 18, 471–478.
   PubMed Web of Science ®Google Scholar
• Cervantes, F., Pierson, BA., McGlave, P.B., Verfaillie, C.M. and Miller, J.S. (1996) "Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture", Blood 87, 2476–2485.
   PubMed Web of Science ®Google Scholar
• Baron, F., Turhan, A.G., Giron-Michel, J., Azzarone, B., Bentires-Alj, M., Bours, V, Bourhis, J.H., Chouaib, S. and Caignard, A. (2002) "Leukemic target susceptibility to natural killer cytotoxicity: relationship with BCR-ABL expression", Blood 99, 2107–2113.
   PubMed Web of Science ®Google Scholar
• Tajima, F. and Kawatani, T. (1996) "Natural killer cell activity and cytokine production as prognostic factors in adult acute leukemia", Leukemia 10, 478–482.
   PubMed Web of Science ®Google Scholar
• Lowdell, MW., Craston, R., Samuel, D., Wood, ME., O'Neill, E., Saha, V. and Prentice, HG. (2002) "Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells", British Journal of Haematology 117, 821–827.
   PubMed Web of Science ®Google Scholar
• Bendall, L.J., Kortlepel, K., Bradstock, K.F. and Gottlieb, D.J. (1995) "Natural killer cells adhere to bone marrow fibroblasts and inhibit adhesion of acute myeloid leukemia cells", Leukemia 9, 999–1005.
   PubMed Web of Science ®Google Scholar
• Grierson, H. and Purtilo, D.T. (1987) "Epstein—Barr virus infections in males with the X-linked lymphoproliferative syndrome", Annals of Internal Medicine 106, 538–545.
   PubMed Web of Science ®Google Scholar
• Matthew, RA., Garni-Wagner, B.A., Land, K., Takashima, A., Stoneman, E., Bennett, M. and Kumar, V. (1993) "Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells", Journal of Immunology 151, 5328–5337.
   Google Scholar
• Parolini, S., Bottino, C., Falco, M., Augugliaro, R., Giliani, S., Franceschini, R., Ochs, RD., Wolf, H., Bonnefoy, J.Y., Biassoni, R., Moretta, L, Notarangelo, L.D. and Moretta, A. (2000) "X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein—Barr virus-infected cells", Journal of Experimental Medicine 192, 337–346.
   PubMed Web of Science ®Google Scholar
• Nichols, K.E. (2000) "X-linked lymphoproliferative disease: genetics and biochemistry", Reviews in Immunogenetics 2, 256–266.
   PubMedGoogle Scholar
• Schuster, V. and Kreth, H.W. (2000) "X-linked lymphoproliferative disease is caused by deficiency of a novel 5H2 domain-containing signal transduction adaptor protein", Immunological Reviews 178, 21 —28.
   PubMed Web of Science ®Google Scholar
• Bottino, C., Falco, M., Parolini, S., Marcenaro, E., Augugliaro, R., Sivori, S., Landi, E., Biassoni, R., Notarangelo, L.D., Morena, L. and Moretta, A. (2001) "NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein—Barr virus-infected B cells in X-linked lymphoproliferative disease", Journal of Experimental Medicine 194, 235–246.
   PubMed Web of Science ®Google Scholar
• Velardi, A., Ruggeri, L, Alessandro, Morena and Morena, L. (2002) "NK cells: a lesson from mismatched hematopoietic transplantation", Trends in Immunology 23, 438–444.
   Google Scholar
• Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M.C. and Morena, L. (1996) "Receptors for HLA class4 molecules in human natural killer cells", Annual Reviews of Immunology 14, 619–648.
   PubMed Web of Science ®Google Scholar
• Salih, RR., Antropius, H., Rammensee, HG. and Steinle, A. (2002) "Expression of MICA and MICB, ligands of the immunoreceptor NKG2D, on leukemia cells: cell surface release and triggering of anti-leukemia activity of cytotoxic lymphocytes", Abstract of the 44th Annual Meeting of the American Society of Hematology, 2157.
   Google Scholar
• Pende, D., Rivera, P., Marcenaro, S., Chang, C.C., Biassoni, R., Conte, R., Kubin, M., Cosman, D., Ferrone, S., Moretta, L. and Moretta, A. (2002) "Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity", Cancer Research 62, 6178–6186.
   PubMed Web of Science ®Google Scholar
• Costello, R.T., Sivori, S., Marcenaro, E., Lafage-Pochitaloff, M., Mozziconacci, M.-J., Reviron, D., Gastaut, J.-A., Pende, D., Olive, D. and Morena, A. (2002) "Defective expression and function of natural killer cell triggering receptors in patients with acute myeloid leukemia", Blood 99, 3661–3667.
   PubMed Web of Science ®Google Scholar
• Salih, RR., Rammensee, HG. and Steinle, A. (2002) "Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding", Journal of Immunology 169, 4098–4102.
   PubMed Web of Science ®Google Scholar
• Girardi, M., Oppenheim, D.E., Steele, CR., Lewis, J.M., Glusac, E., Filler, R., Hobby, P., Sutton, B., Tigelaar, RE. and Hayday, A.C. (2001) "Regulation of cutaneous malignancy by gamma delta T cells", Science 294, 605–609.
   PubMed Web of Science ®Google Scholar
• Arnon, TI., Lev, M., Katz, G., Chernobrov, Y, Porgador, A. and Mandelboim, 0. (2001) "Recognition of viral hemagglutinins by NKp44 but not by NKp30", European Journal of Immunology 31, 2680–2689.
   Google Scholar
• Mandelboim, 0., Lieberman, N., Lev, M., Paul, L, Arnon, Bushkin, Y, Davis, D.M., Strominger, J.L., Yewdell, J.W. and Porgador, A. (2001) "Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells", Nature 409, 1055–1060.
   Google Scholar
• Mandelboim, 0. and Porgador, A. (2001) "NKp46", International Journal of Biochemistry and Cell Biology 33, 1147–1150.
   Google Scholar
• Torelli, G.F., Guarini, A., Palmieri, G., Breccia, M., Vitale, A., Santoni, A. and Foa, R. (2002) "Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remission", British Journal of Haematology 116, 299–307.
   PubMed Web of Science ®Google Scholar
• Sivori, S., Pende, D., Bottino, C., Marcenaro, E., Pessino, A., Biassoni, R., Moretta, L. and Moretta, A. (1999) "NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells", European Journal of Immunology 29, 1656–1666.
   PubMed Web of Science ®Google Scholar
• Del Porto, P., Mami-Chouaib, F., Bruneau, J.M., Jitsukawa, S., Dumas, J., Harnois, M. and Hercend, T. (1991) "TCT.1, a target molecule for gamma/delta T cells, is encoded by an immunoglo-bulin superfamily gene (Blast-1) located in the CD1 region of human chromosome 1", Journal of Experimental Medicine 6, 1339–1344.
   Web of Science ®Google Scholar
• Yokoyama, S., Staunton, D., Fisher, R., Amiot, M., Fortin, J.J. and Thorley-Lawson, D.A. (1991) "Expression of the blast-1 activation/adhesion molecule and its identification as CD48", Journal of Immunology 146, 2192–2200.
   PubMed Web of Science ®Google Scholar
• Costello, R.T., Sivori, S., Mallet, F., Sainty, D., Arnoulet, C., Reviron, D., Gastaut, J.-A., Moretta, A. and Olive, D. (2002) "A novel mechanism of antitumor response involving the expansion of CD3±/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand", Leukemia 16, 855–860.
   Google Scholar
• Parham, P. (2002) "The role of NK cells in post transplant events", Abstract of the 44th Annual Meeting of the American Society of Hematology, 74.
   Google Scholar